madman
Super Moderator
In this episode, Shalin Shah, CEO of Marius Pharmaceuticals and a passionate advocate for testosterone education, shares insights on the misunderstood hormone that impacts both men and women. We dive into myths, testing protocols, treatment options, and the importance of early diagnosis for better health outcomes.
MAIN TOPICS COVERED:
- The role of testosterone in overall health beyond muscle and sex drive
- Common myths surrounding testosterone and TRT
- Why testosterone is often overlooked in medical practice
- The impact of environment, lifestyle, and puberty obesity on testosterone levels
- How testing ranges have shifted over decades and the importance of accurate reference standards
- The advances in oral testosterone therapy and its benefits over traditional injections
- The relationship between testosterone and prostate health, cardiovascular risk, and mortality
- Practical advice on screening, diagnosis, and treatment adherence
- The need for a proactive, preventive approach to hormonal health
Shalin Shah is a distinguished leader in the field of metabolic health, specializing in testosterone replacement therapy. As the Chief Executive Officer of Marius Pharmaceuticals, he was instrumental in the development and FDA approval of KYZATREX®, an oral testosterone treatment for adult men with low or no testosterone levels due to certain medical conditions.
With a global investment background, Shalin transitioned into healthcare with a mission to revolutionize the industry through metabolic health. His leadership at Marius Pharmaceuticals is marked by innovative strategies that prioritize consumer access and education. Under his guidance, KYZATREX has been launched via consumer-focused channels that include preeminent national healthcare institutions, private-equity-backed medical practices, and national telemedicine platforms.
Shalin’s expertise extends beyond corporate leadership; he is an influential voice in longevity medicine and an advocate for reevaluating testosterone medication regulations. His efforts aim to reshape public perception and education on testosterone therapy and its significance for global health. He believes that oral testosterone replacement therapy has created a much-awaited paradigm shift, which is critical for addressing the worldwide men’s (and women’s) health crisis, marked by declining testosterone levels and lower life expectancies. His message is that testosterone replacement therapy is not just about adding years to life but also about adding life to years.
